Trial Profile
Effect of Rosuvastatin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome : Assessment by frequencey domain optical coherence tomography study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes; Hypercholesterolaemia
- Focus Pharmacodynamics
- 17 Jun 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network
- 04 Oct 2013 New trial record